Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

CSE:BNXT - Post Discussion

BioNxt Solutions Inc > Slow and steady wins the race
View:
Post by Franman184 on Apr 06, 2021 7:02pm

Slow and steady wins the race

Spartan Bioscience files for creditor protection after identifying 'issue' with COVID-19 test. Lets not make that mistake.

https://www.cbc.ca/news/canada/ottawa/spartan-bioscience-creditor-protection-1.5976825
Comment by Adwari on Apr 06, 2021 7:35pm
I don't think the Spartan Bioscience Covid-19 kit mistake/ problem is a potential issue or concern with Xphy covid-19 test kit. Looking at the phase that Xphy developed their kit, they have done very gold due diligence to prove that kit works, and is accurate, sensitive and specific. Xphy has not rushed its product for regulatory approval and commercialization. They they developed slowly but ...more  
Comment by wallpaper2 on Apr 09, 2021 6:26am
I think phyto is fully priced if not over priced already. Potential earnings are already built into todays share price. $5 million in promotions this year has kept it above $2 but they can't expect that to last. Jmho.
Comment by RDtrade on Apr 11, 2021 6:23pm
Oh wallpaper are you now saying it was worth the money for promotions? Look at all your posts all negative post. Pretty obvious you continue to try to short it.  Go away!! News this week !!! Excited to see who are the big contracts !!!! 
Comment by wallpaper2 on Apr 12, 2021 11:06am
What I am saying is: - without that outrageous $5 million in promotions the stock would be trading at 75 cents - sooner/later the sheep realize that they aren't looking at their mother but a wolf in sheep clothes - what makes you think the next news will have a different effect on the share price than the last several? - fill your boots, your tying up good money
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities